Perinatal Opioid Use Disorder study: Penny COPILOT
Official title Adapting the Penny Chatbot for Perinatal OUD Patients: COPILOT
ClinicalTrials.gov ID: NCT06969261
What this study is testing
- What it's testing
- The study will see if the adapted chatbot is acceptable, feasible, and satisfactory for these women.
- Who it's for
- Pregnant or postpartum women who use opioids.
- What's involved
- Participants will use a two‑way text messaging chatbot that responds to their messages. The pilot will involve 20 women who will test the system and give feedback.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults, women only
You may be able to join if
- Biological females who are currently pregnant or within 6 weeks postpartum.
- Able to read, write, and speak English at a 6th grade level.
- Diagnosed and receiving treatment for, or willing to receive treatment for opioid use disorder.
- Receiving prenatal care and OUD care at a Penn affiliated hospital.
You likely can't join if
- -Current untreated psychosis, mania, or active suicidality as assessed by the Mini International Neuropsychiatric Interview (MINI).
The study team makes the final eligibility decision.
Where it is enrolling
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.